ABSTRACT
Selective and sensitive methods for the determination of the cationic dye and anti-malarial methylene blue in human liquid whole blood, dried whole blood (paper spot), and plasma depending on protein precipitation and cation exchange chromatography coupled to electrospray ionisation (ESI) tandem mass spectrometry (MS/MS) have been developed, validated according to FDA standards, and applied to samples of healthy individuals and malaria patients within clinical studies. Acidic protein precipitation with acetonitrile and trifluoroacetic acid was used for liquid whole blood and plasma. For the extraction of methylene blue from paper spots aqueous acetonitrile was used. Sample extracts were chromatographed on a mixed mode column (cation exchange/reversed phase, Uptisphere MM1) using an aqueous ammonium acetate/acetonitrile gradient. Methylene blue was quantified with MS/MS in the selected reaction monitoring mode using ESI and methylene violet 3RAX as internal standard. Depending on the sample volume (whole blood and plasma 250 microL, and 100 microL on paper spots) the method was linear at least within 75 and 10,000 ng/mL and the limit of quantification in all matrices was 75 ng/mL. Batch-to-batch accuracies of the whole blood, plasma, and paper spot methods varied between -4.5 and +6.6%, -3.7 and +7.5%, and -5.8 and +11.1%, respectively, with corresponding precision ranging from 3.8 to 11.8% CV. After a single oral dose (500 mg) methylene blue concentrations were detectable for 72 h in plasma. The methods were applied within clinical studies to samples from healthy individuals and malaria patients from Burkina Faso.
Subject(s)
Antimalarials/blood , Chromatography, Ion Exchange/methods , Enzyme Inhibitors/blood , Malaria/blood , Malaria/drug therapy , Methylene Blue/analysis , Tandem Mass Spectrometry/methods , Administration, Oral , Calibration/standards , Cation Exchange Resins/chemistry , Chemical Fractionation/methods , Enzyme Inhibitors/pharmacokinetics , Humans , Molecular Structure , Phenothiazines/blood , Phenothiazines/standards , Quality Control , Reference Standards , Reproducibility of Results , Sensitivity and Specificity , Solid Phase Extraction , Spectrometry, Mass, Electrospray Ionization/methodsABSTRACT
A liquid chromatographic-mass spectrometry (LC/MS) assay method was developed for the determination of amiodarone and desethylamiodarone in rat specimens. Analytes were extracted using liquid-liquid extraction in hexane. The LC/MS system consisted of a Waters Micromass ZQtrade mark 4000 spectrometer with an autosampler and pump. A C(18) 3.5 microm (2.1 x 50 mm) column heated to 45 degrees C was used for separation. The mobile phase consisted of methanol and 0.2% aqueous formic acid pumped at 0.2 mL/min as a linear gradient. Components eluted within 12 min. The concentrations of ethopropazine (internal standard), desethylamiodarone and amiodarone were monitored for m/z of 313.10, combination of 546.9 and 617.73, and 645.83, respectively. In plasma (0.1 mL), linearity was achieved between the peak area ratios and concentrations over the range of 2.5-1000 ng/mL for both amiodarone and desethylamiodarone (r(2) > 0.999). The intraday and interday CV were equal or less than 18%, and mean error was <12%. Similarly, in homogenates containing 0.1 g of rat tissue, linearity was observed in standards ranging from 5 to 5000 ng/g. The method was successfully used to measure tissue and plasma concentrations of drug. The validated lower limit of quantitation was 2.5 ng/mL for drug and metabolite, based on 0.1 mL of plasma.
Subject(s)
Amiodarone/analogs & derivatives , Amiodarone/analysis , Chromatography, High Pressure Liquid/methods , Spectrometry, Mass, Electrospray Ionization/methods , Amiodarone/administration & dosage , Amiodarone/pharmacokinetics , Animals , Calibration/standards , Injections, Intravenous , Linear Models , Molecular Structure , Phenothiazines/standards , Rats , Rats, Sprague-Dawley , Reproducibility of Results , Sensitivity and Specificity , Tissue DistributionSubject(s)
Azure Stains , Phenothiazines , Staining and Labeling/methods , Azure Stains/analysis , Azure Stains/standards , Blood Cells/ultrastructure , Bone and Bones/ultrastructure , Cartilage/ultrastructure , Chromatography, Thin Layer , Methylene Blue/analysis , Phenothiazines/analysis , Phenothiazines/standards , Spectrophotometry , Staining and Labeling/standardsABSTRACT
A liquid chromatographic procedure for the quantitative determination of the thiazine dye azure B, the principal constituent of Romanowsky stains, is presented. Unlike previous methods relying on peak area normalization, the present approach involves real quantitation through calibration with the reference standard azure B tetrafluoroborate. The method has been used for the quality control of commercial azure B preparations and to study their stability in stock and staining solutions, either or not in the presence of eosin Y. Results suggest that highly pure azure B perchlorate meets the requirements of a reference material, useful for standardization of Romanowsky-Giemsa staining in haematology.